Skip to main content

IU Krannert releases 3-Year Impact Report

Between 2021 and 2024, the Krannert Cardiovascular Research Center at Indiana University School of Medicine grew its capacity to deliver impactful cardiovascular research. This illustration shows that among 30 investigators, they have authored 407 publications, 80 of which were published in high impact journals, and that they have garnered more than $85.5 million in grants. IU Krannert also received more than 17,000 website visits and have made more than 142,000 social media impressions.

Between 2021 and 2024, the Krannert Cardiovascular Research Center at Indiana University School of Medicine grew its capacity to deliver impactful cardiovascular research. This illustration shows that among 30 investigators, they have authored 407 publications, 80 of which were published in high impact journals, and that they have garnered more than $85.5 million in grants. IU Krannert also received more than 17,000 website visits and have made more than 142,000 social media impressions.

 The Krannert Cardiovascular Research Center at the Indiana University School of Medicine recently released its Three-Year Impact Report that showcases its achievements in expanding the cardiovascular research program from 2021 to 2024.

Within this short period, IU Krannert:

  • Increased its grant funding from $1.1 million annually to $22 million annually
  • Revamped the cardiovascular clinical trials research program
  • Hosted the two-day Krannert Biennial, which brought to Indianapolis renowned cardiovascular researchers from around the world
  • Launched the first-in-human FDA-approved investigative clinical trial targeting ST Elevation Myocardial Infarction
  • Introduced the world’s first classification of heart attacks based on tissue damage, which has been adopted by the Canadian Cardiovascular Society.

“Much of our success is due to the dedication of our investigative team, students and staff who aspire to advance cardiovascular research and clinical care to benefit the next generation, as well as the many partners and collaborators we have located worldwide,” said Rohan Dharmakumar, PhD, executive director of the Krannert Cardiovascular Research Center and vice chair of the Department of Radiology and Imaging Sciences.

The report includes updates from Rohan Dharmakumar, PhD, Ischemic Heart Disease Research; Ankit A. Desai, MD, Cardiopulmonary Research; Khadijah Breathett, MD, Cardiovascular Equity Research; Thomas H. Everett, PhD and Zhenhui Chen, PhD, Electrophysiology Research; Suparna C. Clasen, MD, Cardiovascular Clinical Research; Behzad Sharif, PhD, Microcirculation Research; Loren J. Field, PhD, Myocardial Regenerative Biology Research; and Bohdan Khomtchouk, PhD, Cardioinformatics Research. It also highlights early investigators, significant milestones and the Krannert Biennial with a photo gallery.